Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Panobinostat/capecitabine/lapatinib combination is safe in HER2+ breast cancer

Dec. 21, 2010

ClanoTech divulges new inhibitors of VEGFR-2 and VEGFR-3

Dec. 21, 2010

UCB claims new PI3K inhibitors

Dec. 21, 2010

Enzon and NCI begin phase I trials of EZN-2968 and EZN-2208

Dec. 20, 2010

Amira Pharma nominates preclinical candidate in LPA-related program

Dec. 20, 2010

Novel Toll-like receptor 7 agonists discovered

Dec. 20, 2010

MM-302 shows promise to treat HER2-overexpressing tumors

Dec. 20, 2010

Merck KGaA and sanofi-aventis to jointly investigate new anticancer agents

Dec. 20, 2010

Jennerex and Transgene begin JX-594 trial in metastatic colorectal cancer

Dec. 17, 2010

Amgen identifies novel inhibitors of PI3K-alpha and/or mTOR

Dec. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...